William Roberts, VP Regulat Development & Med Safety at REGENERON PHARMACEUTICALS INC (REGN), sold 49,000 shares at $186.00 ($2.1M) on 2012-11-30, disclosed to the SEC on 2012-12-04.
Seasonal sale ($2.1M) by VP Regulat Development & Med Safety — this insider has traded REGN in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 26,000 | $0 | 0.0% |
| 2 | $0.00 | 11,500 | $0 | 0.0% |
| 3 | $177.43 | 224 | $40K | 1.9% |
| 4 | $178.27 | 430 | $77K | 3.7% |
| 5 | $179.43 | 2,600 | $467K | 22.4% |
| 6 | $180.67 | 5,010 |
| $905K |
| 43.5% |
| 7 | $181.47 | 1,515 | $275K | 13.2% |
| 8 | $182.44 | 521 | $95K | 4.6% |
| 9 | $183.58 | 800 | $147K | 7.1% |
| 10 | $184.29 | 200 | $37K | 1.8% |
| 11 | $186.00 | 200 | $37K | 1.8% |
| Total | $42.43 avg | 49,000 | $2.1M | 100% |
| Filing → |
| REGN | SELL | 2012-01-11 | $2.4M | — | Filing → |
| REGN | SELL | 2011-09-08 | $1.5M | — | Filing → |
| REGN | SELL | 2011-07-18 | $6K | — | Filing → |